2.85

5.94% -0.18

After Hours: 2.76 -0.09 -3.16%

Indaptus Therapeutics Inc (INDP)

Overview News Price History Financials Discussions Forecast

Indaptus Therapeutics Inc stock is traded at $2.85, with a volume of 92,750. It is down -5.94% in the last 24 hours and down -22.13% over the past month. Indaptus Therapeutics Inc is a clinical biotechnology company that has developed a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. Its approach is based on the hypothesis that efficient activation of both innate and adaptive immune cells and associated anti-tumor and anti-viral immune responses will require a multi-targeted package of immune system activating signals that can be administered safely intravenously. Its patented technology is composed of single strains of attenuated and killed, non-pathogenic, Gram-negative bacteria, designed to have reduced i.v. toxicity, but largely uncompromised ability to prime or activate many of the cellular components of innate and adaptive immunity. Its candidate, Decoy20 is for patients with solid tumors.

Previous Close:

$3.03

Open:

$3.01

24h Volume:

92,750

Relative Volume:

0.10

Market Cap:

$379.74M

Revenue:

Net Income/Loss:

$-18.86M

P/E Ratio:

-0.1775

EPS:

-16.054

Net Cash Flow:

$-17.68M

1W Performance:

-6.86%

1M Performance:

-22.13%

6M Performance:

+10.04%

1Y Performance:

-74.30%

1-Day Range:

$2.61

$3.075

1-Week Range:

$2.61

$3.21

52-Week Range:

$0.92

$13.40

Indaptus Therapeutics Inc Stock (INDP) Company Profile

Name

Indaptus Therapeutics Inc

Sector

Healthcare (1100)

Industry

Biotechnology (615)

Phone

(646) 427-2727

Address

3 COLUMBUS CIRCLE, NEW YORK

Employee

Twitter

Next Earnings Date

2026-08-12

Latest SEC Filings

INDP's Discussions on Twitter

Compare INDP vs VRTX, REGN, ARGX, ALNY, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
INDP Indaptus Therapeutics Inc	2.85	399.73M	0	-18.86M	-17.68M	-16.05
VRTX Vertex Pharmaceuticals Inc	529.59	126.07B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	649.81	65.37B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	916.80	57.70B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	313.04	40.19B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	189.99	39.82B	742.00K	-1.37B	-1.07B	-7.0731

Indaptus Therapeutics Inc Stock (INDP) Latest News

Jun 29, 2026

Indaptus Therapeutics (INDP) News Flow - Moomoo

Jun 29, 2026

Jun 27, 2026

Indaptus Therapeutics Company Profile & Introduction - Moomoo

Jun 27, 2026

Form 13D/A Indaptus Therapeutics For: 26 June By Investing.com - Investing.com Australia

Jun 27, 2026

Jun 26, 2026

Sino Lion Ventures (INDP) files amended 13D on 38,895,000 shares - Stock Titan

Jun 26, 2026

Indaptus Therapeutics (INDP) CEO details 8.44% common stock stake - Stock Titan

Jun 26, 2026

Indaptus (INDP) investor Ting Yang stake falls to 8.44% after share issuance - Stock Titan

Jun 26, 2026

Form S-3 Indaptus Therapeutics Inc For: 26 June By Investing.com - Investing.com South Africa

Jun 26, 2026

Indaptus Therapeutics (INDP) registers 18.864M shares; clinical program paused - Stock Titan

Jun 26, 2026

Jun 25, 2026

Revenue per share of Indaptus Therapeutics, Inc. – NASDAQ:INDP - TradingView

Jun 25, 2026

Jun 24, 2026

INDAPTUS THERAPEUTICSTO ISSUE 20 MLN SHARES AT $0.6 PER SHARESEC FILING - Moomoo

Jun 24, 2026

Indaptus TherapeuticsTo Issue 20 Million Shares At $0.6 Per ShareSEC Filing - TradingView

Jun 24, 2026

Indaptus Therapeutics Announces Private Placement of Common Stock - TipRanks

Jun 24, 2026

Indaptus Therapeutics (INDP) sells 20M shares in $12M Regulation S private placement - Stock Titan

Jun 24, 2026

Indaptus Therapeutics Raises $12 Million in Offshore Private Placement at $0.60 Per Share - TradingView

Jun 24, 2026

Jun 23, 2026